GC interactions with metabolic hormones are complex and have been reviewed elsewhere 60,64,65
This can lead to a decrease in calorie intake and, ultimately, weight loss
Mechanism difference Semaglutide (GLP-1 agonist): appetite regulation, satiety, improved glycemic control (New England Journal of Medicine) Tirzepatide (GLP-1/GIP agonist): broader incretin effects, robust appetite/weight effects (New England Journal of Medicine) AOD-9604: targeted fat-metabolism signaling
Cutting-edge advancements in endocrinology continue to move diabetes treatment in the right direction faster than ever before
You have low levels of B12 in your cells
Therefore, modulating the gut microbiota via dietary interventions, especially increasing the abundance of butyrate-producing bacteria, may offer a feasible strategy to counteract T2D and associated metabolic abnormalities 11